BTYNB
BTYNB is a potent and selective inhibitor of IMP1 binding to c-Myc mRNA (IC50=5 μM) . BTYNB exhibits selectivity and effectiveness against IMP1-postive cancer cell lines. BTYNB can be used for cancer research[1].
Product Specifications
CAS Number
304456-62-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
C-Myc
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/btynb.html
Concentration
10mM
Purity
98.0
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CC=C1/N=C/C2=CC=C(S2)Br)N
Molecular Formula
C12H9BrN2OS
Molecular Weight
309.18
Precautions
H302, H315, H319, H335
References & Citations
[1]Lily Mahapatra, et al. A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation. Transl Oncol
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4690802 1.0 µg DNA
E4f1 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
